P-167. The Utility of Microbial Cell Free DNA in the Rapid Diagnosis of Acute Chagas Disease

Abstract Background Chagas disease (CD), caused by Trypanosoma cruzi, is a vector-borne infection with potentially severe cardiac and neurological complications during acute infection or reactivation. Endemic to Latin America, sporadic cases also occur in the United States. Diagnosis of acute CD is by microscopy of whole blood or tissue and/or a polymerase chain reaction (PCR) test, however, sensitivity of microscopy may be lower in labs that do not routinely perform it. PCR is more sensitive and is available through commercial send-out labs, but due to the non-specific nature of acute CD, diagnosis is less likely to be considered outside of highly endemic areas. Microbial cell-free DNA (mcfDNA) testing, such as the Karius Spectrum® test, is a noninvasive diagnostic modality with broad pathogen detection. Karius may be particularly valuable when the diagnosis is not suspected or when infection is suspected but there are delays or barriers to traditional testing. Here we report five cases—one child and four adults—of CD diagnosed by microbial cell-free DNA testing.Figure 1.Echocardiogram of a 12-month-old male showing thrombus. A: Thrombus in the left ventricle apex measuring 6x7 mm and 6x6 mm, bilobed or two adjacent clots. Small to moderate pericardial effusion. B: Resolution of left ventricle thrombus.Figure 2.Brain MRI of an 88-year-old female with necrotizing encephalitis demonstrating bilateral frontoparietal enhancing white matter changes and surrounding vasogenic edema. Methods We collected clinical, laboratory and demographic information on patients diagnosed with CD using the Karius Spectrum® test, turnaround time, and impact on the management of the patients at four institutions: Driscoll Children’s Hospital, Dell Medical Center, Froedtert Hospital, and UCLA Medical Center.Figure 3.Chagoma on upper right arm of a 71-year-old female presenting as a raised, circular erythematous lesion (∼5 cm).Figure 4.41-year-old male with Romana’s sign on left eye. Results Five patients (4 adults, 1 child) tested positive for T. cruzi by the Karius Spectrum® test; diagnosis was not initially suspected in four. One case involved suspected Chagas reactivation. Patients (2 male, 3 female; ages 12 months–88 years) presented with fever and variable symptoms. Four were started on empiric therapy before results. Test turnaround was 2–5 days. Three improved after treatment; two expired. Case 1: 12-month-old male with cardiomyopathy (Figure 1). Case 2: 88-year-old female with necrotizing encephalitis (Figure 2). Case 3: 71-year-old female with Chagoma and cellulitis (Figure 3). Case 4: 41-year-old male with orbital cellulitis (Figure 4). Case 5: 50-year-old female with reactivation of known CD. Conclusion The detection of microbial cell free DNA in blood can rapidly confirm the diagnosis of Chagas disease and it is a particularly valuable test when the diagnosis is not clinically suspected. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.391
Primary Topic
Trypanosoma species research and implications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-167. The Utility of Microbial Cell Free DNA in the Rapid Diagnosis of Acute Chagas Disease

Omer E. Beaird, Kristin Mondy, Michael Kron, Niki Viradia et al.
Open Forum Infectious Diseases
Trypanosoma species research and implications
article

P-167. The Utility of Microbial Cell Free DNA in the Rapid Diagnosis of Acute Chagas Disease

Omer E. Beaird, Kristin Mondy, Michael Kron, Niki Viradia, Jaime Fergie, Anissa Amilhamja, Adam Shaikh
article en

Abstract

Abstract Background Chagas disease (CD), caused by Trypanosoma cruzi, is a vector-borne infection with potentially severe cardiac and neurological complications during acute infection or reactivation. Endemic to Latin America, sporadic cases also occur in the United States. Diagnosis of acute CD is by microscopy of whole blood or tissue and/or a polymerase chain reaction (PCR) test, however, sensitivity of microscopy may be lower in labs that do not routinely perform it. PCR is more sensitive and is available through commercial send-out labs, but due to the non-specific nature of acute CD, diagnosis is less likely to be considered outside of highly endemic areas. Microbial cell-free DNA (mcfDNA) testing, such as the Karius Spectrum® test, is a noninvasive diagnostic modality with broad pathogen detection. Karius may be particularly valuable when the diagnosis is not suspected or when infection is suspected but there are delays or barriers to traditional testing. Here we report five cases—one child and four adults—of CD diagnosed by microbial cell-free DNA testing.Figure 1.Echocardiogram of a 12-month-old male showing thrombus. A: Thrombus in the left ventricle apex measuring 6x7 mm and 6x6 mm, bilobed or two adjacent clots. Small to moderate pericardial effusion. B: Resolution of left ventricle thrombus.Figure 2.Brain MRI of an 88-year-old female with necrotizing encephalitis demonstrating bilateral frontoparietal enhancing white matter changes and surrounding vasogenic edema. Methods We collected clinical, laboratory and demographic information on patients diagnosed with CD using the Karius Spectrum® test, turnaround time, and impact on the management of the patients at four institutions: Driscoll Children’s Hospital, Dell Medical Center, Froedtert Hospital, and UCLA Medical Center.Figure 3.Chagoma on upper right arm of a 71-year-old female presenting as a raised, circular erythematous lesion (∼5 cm).Figure 4.41-year-old male with Romana’s sign on left eye. Results Five patients (4 adults, 1 child) tested positive for T. cruzi by the Karius Spectrum® test; diagnosis was not initially suspected in four. One case involved suspected Chagas reactivation. Patients (2 male, 3 female; ages 12 months–88 years) presented with fever and variable symptoms. Four were started on empiric therapy before results. Test turnaround was 2–5 days. Three improved after treatment; two expired. Case 1: 12-month-old male with cardiomyopathy (Figure 1). Case 2: 88-year-old female with necrotizing encephalitis (Figure 2). Case 3: 71-year-old female with Chagoma and cellulitis (Figure 3). Case 4: 41-year-old male with orbital cellulitis (Figure 4). Case 5: 50-year-old female with reactivation of known CD. Conclusion The detection of microbial cell free DNA in blood can rapidly confirm the diagnosis of Chagas disease and it is a particularly valuable test when the diagnosis is not clinically suspected. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 13(Supplement_1)
University of California, Los Angeles (US), Medical College of Wisconsin (US), Driscoll Children's Hospital (US), The University of Texas at Austin (US)
Good health and well-being
Openalex Percentile: Top 91%
Trypanosoma species research and implications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.